• Busam, K.J., Iversen, K., Coplan, K.C., and Jungbluth, A.A. (2001). Analysis of microphthalmia transcription factor expression in normal tissues and tumors, and comparison of its expression with S-100 protein, gp100, and tyrosinase in desmoplastic malignant melanoma. Am. J. Surg. Pathol. 25, 197204.
  • Campoli, M.R., Chang, C.C., Kageshita, T., Wang, X., Mccarthy, J.B., and Ferrone, S. (2004). Human high molecular weight-melanoma-associated antigen (HMW-MAA): a melanoma cell surface chondroitin sulfate proteoglycan (MSCP) with biological and clinical significance. Crit. Rev. Immunol. 24, 267296.
  • Goto, Y., Ferrone, S., Arigami, T., Kitago, M., Tanemura, A., Sunami, E., Nguyen, S.L., Turner, R.R., Morton, D.L., and Hoon, D.S. (2008). Human high molecular weight-melanoma-associated antigen: utility for detection of metastatic melanoma in sentinel lymph nodes. Clin. Cancer Res. 14, 34013407.
  • Granter, S.R., Weilbaecher, K.N., Quigley, C., Fletcher, C.D., and Fisher, D.E. (2001). Microphthalmia transcription factor: not a sensitive or specific marker for the diagnosis of desmoplastic melanoma and spindle cell (non-desmoplastic) melanoma. Am. J. Dermatopathol. 23, 185189.
  • Gyorki, D.E., Busam, K., Panageas, K., Brady, M.S., and Coit, D.G. (2003). Sentinel lymph node biopsy for patients with cutaneous desmoplastic melanoma. Ann. Surg. Oncol. 10, 403407.
  • Koch, M.B., Shih, I.M., Weiss, S.W., and Folpe, A.L. (2001). Microphthalmia transcription factor and melanoma cell adhesion molecule expression distinguish desmoplastic/spindle cell melanoma from morphologic mimics. Am. J. Surg. Pathol. 25, 5864.
  • Longacre, T.A., Egbert, B.M., and Rouse, R.V. (1996). Desmoplastic and spindle-cell malignant melanoma. An immunohistochemical study. Am. J. Surg. Pathol. 20, 14891500.
  • Mccarthy, S.W., Scolyer, R.A., and Palmer, A.A. (2004). Desmoplastic melanoma: a diagnostic trap for the unwary. Pathology 36, 445451.
  • Morton, D.L., Thompson, J.F., Cochran, A.J. et al. (2006). Sentinel-node biopsy or nodal observation in melanoma. N. Engl. J. Med. 355, 13071317.
  • Pawlik, T.M., Ross, M.I., Prieto, V.G., Ballo, M.T., Johnson, M.M., Mansfield, P.F., Lee, J.E., Cormier, J.N., and Gershenwald, J.E. (2006). Assessment of the role of sentinel lymph node biopsy for primary cutaneous desmoplastic melanoma. Cancer 106, 900906.
  • Quinn, M.J., Crotty, K.A., Thompson, J.F., Coates, A.S., O’brien, C.J., and Mccarthy, W.H. (1998). Desmoplastic and desmoplastic neurotropic melanoma: experience with 280 patients. Cancer 83, 11281135.
  • Thelmo, M.C., Sagebiel, R.W., Treseler, P.A., Morita, E.T., Nguyen, L.H., Kashani-Sabet, M., and Leong, S.P. (2001). Evaluation of sentinel lymph node status in spindle cell melanomas. J. Am. Acad. Dermatol. 44, 451455.